Evidence map›Paper›PMID 41950159›Full record

ArticleHormone research in paediatrics2026

<italic>MKRN3</italic> Variants in Central Precocious Puberty as an Example of the Complexity to Classify Missense Variants in Imprinted Genes as Pathogenic.

Clémence Delcour, Carole Harbulot, Leila Drira, Kathy Wagner Malher, Delphine Zenaty, George Gelwane, Dominique Simon, Mélanie Amouyal, Maryse Cartigny Maciejewski, Hélène Bony and 8 more

Abstract read
In one paragraph

Article in Hormone research in paediatrics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Clémence DelcourService de gynécologie obstétrique, hôpital Robert Debré, APHP, Paris, France.
Carole HarbulotUniversité Paris Cité, Inserm U1141 NeuroDiderot, Paris, France.
Leila DriraService de biochimie et hormonologie, Hôpital Robert Debré, Paris, France.
Kathy Wagner MalherService d'endocrinologie pédiatrique, CHU de Nice, Nice, France.
Delphine ZenatyAP-HP, Nord Université Paris Cité, Service d'Endocrinologie et Diabétologie Pédiatrique, Centre de Référence Maladies Endocriniennes Rares de la Croissance et du Développement, Hôpital Universitaire Robert-Debré, Paris, France.
George GelwaneAP-HP, Nord Université Paris Cité, Service d'Endocrinologie et Diabétologie Pédiatrique, Centre de Référence Maladies Endocriniennes Rares de la Croissance et du Développement, Hôpital Universitaire Robert-Debré, Paris, France.
Dominique SimonAP-HP, Nord Université Paris Cité, Service d'Endocrinologie et Diabétologie Pédiatrique, Centre de Référence Maladies Endocriniennes Rares de la Croissance et du Développement, Hôpital Universitaire Robert-Debré, Paris, France.
Mélanie AmouyalAP-HP, Nord Université Paris Cité, Service d'Endocrinologie et Diabétologie Pédiatrique, Centre de Référence Maladies Endocriniennes Rares de la Croissance et du Développement, Hôpital Universitaire Robert-Debré, Paris, France.
Maryse Cartigny MaciejewskiService d'endocrinologie pédiatrique, CHU Jeanne de Flandres, Lille, France.
Hélène BonyService de pédiatrie et médecine de l'adolescent, CHU Amiens - Picardie, Amiens, France.
Axelle CauliezService de pédiatrie et médecine de l'adolescent, CHU Amiens - Picardie, Amiens, France.
Aurélie DonzeauService d'endocrinologie pédiatrique, CHU Angers, Angers, France.
Rachel ReynaudService d'endocrinologie pédiatrique, CHU La Timone, APHM, Marseille, France.
Catherine Brue FabreService d'endocrinologie pédiatrique, CHU La Timone, APHM, Marseille, France.
Isam Al-Amir AhmadService de biochimie et hormonologie, Hôpital Robert Debré, Paris, France.
Juliane LégerUniversité Paris Cité, Inserm U1141 NeuroDiderot, Paris, France.
Jean-Claude CarelUniversité Paris Cité, Inserm U1141 NeuroDiderot, Paris, France.
Nicolas de RouxUniversité Paris Cité, Inserm U1141 NeuroDiderot, Paris, France, nicolas.deroux@inserm.fr.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionMakorin ring-finger protein 3 (MKRN3) is a maternally imprinted gene, and variants of this gene have been associated with central precocious puberty (CPP). To date, the biochemical function of MKRN3 is still uncertain. The aim of this study was to assess American College of Medical Genetics and Genomics (ACMG) criteria for pathogenic classification of missense variants of MKRN3 and to propose specific ACMG criteria for this gene.

methodsMKRN3 missense variants from our cohort of CPP or the HGMD (considered pathogenic) and gnomAD (considered benign) databases were annotated by diverse in silico analysis tools. Performance of these tools was assessed by determining sensitivity, specificity, and positive and negative predictive values. We then assessed the relevance of using amino acid conservation between MKRN family proteins and the population constraint as additional criteria to annotate missense variants.

resultsUsual in silico tools showed limited ability to distinguish the deleterious effect of pathogenic from benign variants. Analyses of amino acid conservation between MKRN family proteins and population constraints facilitated characterization of the damaging effect of MKRN3 missense variants. Revised ACMG criteria expanding familial segregation, conservation within the MKRN protein family, and population constraint allowed reclassification of several uncertain significant variants to likely pathogenic.

conclusionThis study highlights the challenge involved in the classification of missense variants of a maternally imprinted gene. Expanding familial segregation over three generations, protein-family conservation, and population constraint improve the accuracy of MKRN3 variant annotation in CPP.

Indexed as

ACMGConservationIn silico analysisMKRN3Population constraintPuberty

Identifiers

PMID41950159
PMCPMC13275053

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.